Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2023

Managing disease progression in oncogene-driven lung cancer

Managing progression after EGFR TKIs in EGFR-mutant lung cancer

Date

21 Oct 2023

Session

Managing disease progression in oncogene-driven lung cancer

Topics

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Myung-Ju Ahn

Authors

M. Ahn

Author affiliations

  • Hematology-oncology Department, Samsung Medical Center (SMC) - Sungkyunkwan University School of Medicine, 135-710 - Seoul/KR

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Mechanisms of resistance

Presenter: Anne-Marie Baird

Session: Managing disease progression in oncogene-driven lung cancer

Resources:

Slides

Webcast

Discussion

Presenter: All Speakers

Session: Managing disease progression in oncogene-driven lung cancer

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.